Final results of the phase 1/2, open-label clinical study of intravenous recombinant human N-acetyl-α-D-glucosaminidase (SBC-103) in children with mucopolysaccharidosis IIIB

Chester B. Whitley, Suresh Vijay, Bert Yao, Mercé Pineda, Geoff J.M. Parker, Sandra Rojas-Caro, Xiaoping Zhang, Yang Dai, Amy Cinar, Gillian Bubb, Kiran C. Patki, Maria L. Escolar

Research output: Contribution to journal › Article › peer-review

16 Scopus citations

Fingerprint

Dive into the research topics of 'Final results of the phase 1/2, open-label clinical study of intravenous recombinant human N-acetyl-α-D-glucosaminidase (SBC-103) in children with mucopolysaccharidosis IIIB'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds